Carregant...
Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone
OBJECTIVES: Amiodarone is a commonly used anti-arrhythmic drug. Hepatotoxicity following chronic oral administration occurs in 1% to 3% of patients. Hepatotoxicity following intravenous (IV) administration is infrequent but may be associated with dramatic increases in serum transaminases. We describ...
Guardat en:
| Publicat a: | South Med J |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4743550/ https://ncbi.nlm.nih.gov/pubmed/26840961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14423/SMJ.0000000000000413 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|